Skip to content

A P300 Brain Computer Interface to Operate Power Wheelchair Tilt

A P300 Brain Computer Interface to Operate Power Wheelchair Tilt

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01123148
Enrollment
16
Registered
2010-05-14
Start date
2010-01-31
Completion date
2010-08-31
Last updated
2016-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis, Healthy

Keywords

Brain computer interface, wheelchair control

Brief summary

The investigators want to develop a brain-computer interface (BCI) that will eventually allow people who are completely paralyzed to independently control the tilt feature on their power wheelchairs. This study will allow healthy volunteers to test the feasibility and accuracy of controlling a BCI using only their brain signals while seated in a tilting wheelchair.

Interventions

DEVICEUsing a BCI to control wheelchair tilt

Subjects will wear an EEG cap for 1-4 hours (1-2 hours typical) during each session and use a P300 based BCI to type words and control wheelchair tilt. Subjects will be asked to participate in 3 sessions.

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18 or older. * Able to read text on a computer screen * Able to understand and remember instructions concerning participation.

Exclusion criteria

* Unable give informed consent. * Unable to understand and follow instructions. * Have abnormal tone or uncontrolled movements in the head-and-neck that would interfere with EEG recordings. * Known to have photosensitive epilepsy. * Open head lesions or sores.

Design outcomes

Primary

MeasureTime frameDescription
The Accuracy of BCI Typing While Tilting in a Power Wheelchair and While Sitting Still in a Power Wheelchair.3 1-2 hour sessions over 2-4 weeksSubjects will participate in 3 sessions. During each session each subject will copy a word in each of 3 conditions (no-movement, self-movement, continuous movement) by typing using only brainwaves. For the no-movement condition, the wheelchair seat remains in a fixed position. For the self-movement condition, the angle of the wheelchair seat changes in response to some of the selections made with the brain-computer interface. For the continuous movement condition, the angle of the wheelchair seat moves continuously. Changes in the wheelchair's position may affect spelling accuracy. The accuracy of the subject's copy spelling of the designated word will be measured for each condition in each session. The order of the conditions is balanced across the three days. The accuracy for each subject in each condition is presented as the average of the accuracies for that condition across the three days.

Participant flow

Pre-assignment details

Of the 16 people consented, 2 were pilot subjects, not intended for inclusion in the final analysis. They helped to test the protocol and set-up for the planned data collection session to make sure that the instructions for future subjects were clear and that all equipment was working correctly.

Participants by arm

ArmCount
Tilt Testing
Using a BCI to control wheelchair tilt: Subjects will wear an EEG cap for 1-4 hours (1-2 hours typical) during each session and use a P300 based BCI to type words and control wheelchair tilt. Subjects will be asked to participate in 3 sessions.
12
Total12

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyCoughing caused unacceptable EEG quality1
Overall StudyDidn't meet milestone criteria1

Baseline characteristics

CharacteristicTilt Testing
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
12 Participants
Age, Continuous40.5 years
Region of Enrollment
United States
12 participants
Sex: Female, Male
Female
8 Participants
Sex: Female, Male
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 16
serious
Total, serious adverse events
0 / 16

Outcome results

Primary

The Accuracy of BCI Typing While Tilting in a Power Wheelchair and While Sitting Still in a Power Wheelchair.

Subjects will participate in 3 sessions. During each session each subject will copy a word in each of 3 conditions (no-movement, self-movement, continuous movement) by typing using only brainwaves. For the no-movement condition, the wheelchair seat remains in a fixed position. For the self-movement condition, the angle of the wheelchair seat changes in response to some of the selections made with the brain-computer interface. For the continuous movement condition, the angle of the wheelchair seat moves continuously. Changes in the wheelchair's position may affect spelling accuracy. The accuracy of the subject's copy spelling of the designated word will be measured for each condition in each session. The order of the conditions is balanced across the three days. The accuracy for each subject in each condition is presented as the average of the accuracies for that condition across the three days.

Time frame: 3 1-2 hour sessions over 2-4 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Tilt TestingThe Accuracy of BCI Typing While Tilting in a Power Wheelchair and While Sitting Still in a Power Wheelchair.BCI Controlled Movement91.18 % Accuracy of selectionsStandard Deviation 6.36
Tilt TestingThe Accuracy of BCI Typing While Tilting in a Power Wheelchair and While Sitting Still in a Power Wheelchair.Continuous Movement88.38 % Accuracy of selectionsStandard Deviation 11.69
Tilt TestingThe Accuracy of BCI Typing While Tilting in a Power Wheelchair and While Sitting Still in a Power Wheelchair.No Movement91.04 % Accuracy of selectionsStandard Deviation 6.93

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026